loading animation for AJAX calls

270 Reports in Cell Biology

Switching to CRISPR-Cas Systems from Uncultivated Microbes

Published - Sep 2018 | Publisher - BCC Publishing| Code - BIO172A

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.

Current Research & Developments Status of Chimeric Antigen Recept...

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO162A

The global market for Chimeric Antigen Receptor (CAR) T-cell therapies will grow from nearly $467.0 million in 2018 to $2.9 billion by 2023 at a compound annual growth rate (CAGR) of 44.1% for the period of 2018-2023.

Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO171A

Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnosti...

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO157A

The global market for polymerase chain reaction (PCR) in point of care (POC) diagnostics totaled $2.9 billion in 2018 and is estimated to reach $4.8 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.6% for the period of 2018-2023.

Microbial Products: Technologies, Applications and Global Markets

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO086D

The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.

Immunohistochemistry (IHC): Global Markets to 2022

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO161A

The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.

Global Markets for Media, Sera and Reagents in Biotechnology

Published - Aug 2018 | Publisher - BCC Publishing| Code - BIO014K

The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.

Synthetic Biology: Global Markets

Published - Jul 2018 | Publisher - BCC Publishing| Code - BIO066E

The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Cardiac Biomarkers: Technologies and Global Markets

Published - Jul 2018 | Publisher - BCC Publishing| Code - BIO128C

The global market for cardiac biomarker will grow from $6.3 billion in 2017 to $9.9 billion by 2022, at a compound annual growth rate (CAGR) of 9.5% for the period of 2017-2022

Digital Polymerase Chain Reaction (PCR) Technology: Global Market...

Published - Jun 2018 | Publisher - BCC Publishing| Code - BIO137B

The global digital polymerase chain reaction (PCR) technology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.

Exosome Diagnostics and Therapeutics: Global Markets

Published - Jun 2018 | Publisher - BCC Publishing| Code - BIO149B

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

The Chinese Market for DNA Sequencing

Published - Jun 2018 | Publisher - BCC Publishing| Code - BIO152B

The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.

Artificial Blood: Global Markets to 2027

Published - Apr 2018 | Publisher - BCC Publishing| Code - BIO164A

The global market for potential artificial blood is estimated to grow from nearly $6.2 billion in 2022 to $15.6 billion by 2027 with a compound annual growth rate (CAGR) of 20.5% for the period of 2022-2027.

Biosimilars: Global Markets

Published - Apr 2018 | Publisher - BCC Publishing| Code - BIO090C

The global biosimilars market reached nearly $5.5 billion in 2017 and is expected to reach $20.8 billion by 2022, with a compound annual growth rate (CAGR) of 30.5% from 2017 through 2022.

Cell Therapy Processing: Global Markets and Technologies

Published - Apr 2018 | Publisher - BCC Publishing| Code - BIO160A

The global market for cell therapy reached $1.3 billion in 2017 and should reach $5.0 billion in 2022 at a compound annual growth rate (CAGR) of 30.9% for the period of 2017-2022.

The Global Market for Stem Cells

Published - Apr 2018 | Publisher - BCC Publishing| Code - BIO035G

The global market for stem cells totaled $7.4 billion in 2017 and is estimated to reach $14.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 14.7% for the period of 2017-2022.

Biologics Development and Manufacturing Testing: Technologies and...

Published - Mar 2018 | Publisher - BCC Publishing| Code - BIO155A

The global biological safety testing market should reach $13.1 billion by 2022 from $5.1 billion in 2017 at a compound annual growth rate (CAGR) of 20.9%, from 2017 to 2022.

Mobile Apps for DNA Sequencing: Global Markets

Published - Mar 2018 | Publisher - BCC Publishing| Code - BIO156A

The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.

Drug Discovery Technologies

Published - Feb 2018 | Publisher - BCC Publishing| Code - BIO020F

The global market for drug discovery technologies totaled $54.7 billion in 2017. The market should reach $85.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 9.4% during 2017-2022.

Global Markets for Research Antibodies

Published - Jan 2018 | Publisher - BCC Publishing| Code - BIO141B

The global market for research antibodies should reach $3.0 billion by 2022 from $2.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.8%, from 2017 to 2022.

Single-cell Omics: Emerging Technologies and Markets

Published - Jan 2018 | Publisher - BCC Publishing| Code - BIO143B

The global single-cell omics market is expected to grow from $555.3 million in 2017 to nearly $1.6 billion in 2022, at a compound annual growth rate (CAGR) of 23.5% from 2017 to 2022.

Cancer Stem Cells: Technologies and Global Markets

Published - Jan 2018 | Publisher - BCC Publishing| Code - BIO158A

The global market for cancer stem cells will grow from $745 million in 2017 to $1.9 billion by 2022 with a compound annual growth rate (CAGR) of 21.2% for the period of 2017-2022.

Global Markets for Enzyme Inhibitors

Published - Jan 2018 | Publisher - BCC Publishing| Code - BIO057C

The global market for enzyme inhibitors should reach $179.9 billion by 2022 from $168 billion in 2017 at a compound annual growth rate (CAGR) of 1.4%, from 2017 to 2022.

Botanical and Plant-derived Drugs: Global Markets

Published - Dec 2017 | Publisher - BCC Publishing| Code - BIO022H

The global market for botanical and plant-derived drugs will grow from $29.4 billion in 2017 to around $39.6 billion by 2022 with a compound annual growth rate (CAGR) of 6.1% for the period of 2017-2022.

Commercial Amino Acids

Published - Nov 2017 | Publisher - BCC Publishing| Code - BIO007L

The U.S. amino acid market was valued at around $1.9 billion in 2016. This market will grow from nearly $2.0 billion in 2017 to $2.5 billion by 2022 with a compound annual growth rate (CAGR) of 4.8% for the period of 2017-2022.

« 1 2 3 4 5 »

9 Upcoming Reports in Cell Biology

Cloud Computing for Cell Biology, Genomics, and Drug Design

Target Date - Mar 2020| Publisher - BCC Publishing | Code - BIO200A| Price - $5,500

Get information on the recent developments in cloud infrastructure, and insights into government funding and investment in R&D for biocloud.

Agricultural Biotechnology: Emerging Technologies and Global Markets

Target Date - Mar 2020| Publisher - BCC Publishing | Code - BIO100D| Price - $5,500

This report provides detailed review of the global markets for agricultural biotechnology and other emerging technologies

Genomics and Proteomic Tools for Emerging Markets in Asia-Pacific

Target Date - Mar 2020| Publisher - BCC Publishing | Code - BIO201A| Price - $5,500

The report would cover the Genomics and Proteomics Tools market, dynamics and competitive landscape of the Emerging markets in the Asia-Pacific. Key countries to be covered include - China, South Korea and India.

Biologic Therapeutic Drugs: Technologies and Global Markets

Target Date - Apr 2020| Publisher - BCC Publishing | Code - BIO079D| Price - $4,950

This report provides comprehensive analysis of biologics, or biopharmaceuticals, on a global basis. it also gives information, from detailed product analyses within disease subsegments to overall industry trends.

Artificial Intelligence (AI) in Alzheimer's

Target Date - Apr 2020| Publisher - BCC Publishing | Code - BIO195A| Price - $3,950

An overview of the global market of artificial intelligence (AI) and a detailed review of how AI is being applied in fighting Alzheimer disease. 

3D Cell Cultures: Technologies and Global Markets

Target Date - May 2020| Publisher - BCC Publishing | Code - BIO140C| Price - $5,500

Examine 3D cell cultures technologies with current market status, future market drivers and its growth potential over the five-year period from 2019 to 2024.

Artificial Intelligence (AI) in Cancer

Target Date - Jun 2020| Publisher - BCC Publishing | Code - BIO196A| Price - $3,950

Detailed review of artificial intelligence (AI) applications in the diagnosis and treatment of cancer diseases. Coverage of different AI algorithm types -- artificial neural networks and deep learning -- and their feasible healthcare applications in the field of cancer

Immunoassays: Technologies and Global Markets

Target Date - Jul 2020| Publisher - BCC Publishing | Code - BIO033C| Price - $5,500

Get an overview of global market for cell and gene therapy tools and information on their importance in treating human health.

Artificial Intelligence (AI) in HIV/AIDS

Target Date - Jul 2020| Publisher - BCC Publishing | Code - BIO197A| Price - $3,950

An overview of the artificial intelligence (AI) applications in fighting against HIV/AIDS-related illnesses. Discussion of recent achievements and breakthrough therapies related to HIV/AIDS disease segments.

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM